speb/financial-data huggingface dataset:
Financial ratios for RX.V — quarterly report dated 2025-09-30
Total revenue: 8792664.74820144
Gross profit: 6666848.92086331
Operating income: 2452298.5611510794
Net income: 1929741.0071942448
Capital expenditures: 1217.2661870503598
Operating cash flow: 1992079.1366906476
Depreciation & amortization: 145471.22302158276
Net tangible assets: 25146717.985611513
Owner earnings: 2073994.964028777
Return on net tangible assets (%): 8.247577139949152
Capex to operating income (%): 0.0496377645990621
Buffett classification: The Great
Stock price: 8.208633093525181
P/E ratio: 18.51074881695903
Shares outstanding: 11331974
Book value: 28707100
P/B ratio: 3.240313956873628
Market cap (USD): 93020016.79136692
Debt to equity: 0.02237628577534112
Current ratio: 5.061293082341551
Quick ratio: 4.231184762633782
Effective tax rate (%): 26.49999643781159
Interest coverage ratio: 280.7589984350548
COGS to revenue (%): 24.17715093451016
R&D to revenue (%): 1.0432175151884289
SG&A to revenue (%): 42.31119235752758
Free cash flow (dilution-adjusted): 1705271.223021583
Buyback yield (%): 0.2530382890821524
Retained earnings: 23613646.76258993
Inventory turnover: 0.5008817899692238
Receivables turnover: 1.929385444098862
Capitalized R&D asset: 135799.83824462048
ROCI (R&D-adjusted, %): 8.438315564419806
Rosenberg metric: 25.467650208216583
FCF margin (%): 19.394248181365047
Revenue growth (%): 18.337758377750028
Rule of 40 score: 37.73200655911508
Financial ratios for RX.V — annual report dated 2025-12-31
Total revenue: 31424805.10948905
Gross profit: 24060604.379562043
Operating income: 8257776.642335766
Net income: 6578271.532846714
Capital expenditures: 39448.17518248175
Operating cash flow: 6576018.9781021895
Depreciation & amortization: 622256.2043795619
Net tangible assets: 26765279.562043793
Owner earnings: 7161079.562043795
Return on net tangible assets (%): 26.755108406186874
Capex to operating income (%): 0.47770939916490124
Buffett classification: The Great
Stock price: 9.21897810218978
P/E ratio: 15.880952867169864
Shares outstanding: 11331974
Book value: 30266792.700729925
P/B ratio: 3.4516118438299053
Market cap (USD): 104469220.16058393
Debt to equity: 0.02028442628916671
Current ratio: 5.5148451800596705
Quick ratio: 4.625633349261767
Effective tax rate (%): 25.08542801121063
Interest coverage ratio: 229.22930723562905
COGS to revenue (%): 23.434356089938994
R&D to revenue (%): 0.7921795379320855
SG&A to revenue (%): 45.976170249811716
Free cash flow (dilution-adjusted): 5835565.693430657
Buyback yield (%): 0.1502206164917407
Retained earnings: 24993419.708029196
Inventory turnover: 1.5724180527925857
Receivables turnover: 9.489175894768234
Capitalized R&D asset: 350052.26926905214
ROCI (R&D-adjusted, %): 26.829193985820975
Rosenberg metric: 38.22417336904717
FCF margin (%): 18.569934397679198
Revenue growth (%): 28.279533654446066
Rule of 40 score: 46.84946805212526
Financial ratios for RX.V — quarterly report dated 2025-12-31
Total revenue: 7059797.810218978
Gross profit: 5435294.890510948
Operating income: 1743989.7810218977
Net income: 1453859.8540145985
Capital expenditures: 10016.788321167882
Operating cash flow: 2545572.2627737224
Depreciation & amortization: 165300.72992700728
Net tangible assets: 26765279.562043793
Owner earnings: 1609143.795620438
Return on net tangible assets (%): 6.012056746466368
Capex to operating income (%): 0.5743604939759741
Buffett classification: The Great
Stock price: 9.21897810218978
P/E ratio: 16.12415923434417
Shares outstanding: 11331974
Book value: 30266792.700729925
P/B ratio: 3.4516118438299053
Market cap (USD): 104469220.16058393
Debt to equity: 0.02028442628916671
Current ratio: 5.5148451800596705
Quick ratio: 4.625633349261767
Effective tax rate (%): 19.633729666218525
Interest coverage ratio: 208.16048092002092
COGS to revenue (%): 23.010615365734406
R&D to revenue (%): 0.7881059433579032
SG&A to revenue (%): 47.065500831634
Free cash flow (dilution-adjusted): 2416964.2335766423
Buyback yield (%): 0.5456522842375552
Retained earnings: 24993419.708029196
Inventory turnover: 0.34686693253518747
Receivables turnover: 2.1318083905137297
Capitalized R&D asset: 128644.07540828652
ROCI (R&D-adjusted, %): 5.618414144961411
Rosenberg metric: -13.42635374266496
FCF margin (%): 34.23560133801727
Revenue growth (%): -19.708097460862746
Rule of 40 score: 14.527503877154523
Financial ratios for SAKAR.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7822761440063302
Shares outstanding: 21949910
Market cap (USD): 39120800.95608599
Buyback yield (%): 0
Retained earnings: 7398931.821178953
Capitalized R&D asset: 15033.627851773705
Rule of 40 score: 0
Financial ratios for SAKAR.NS — annual report dated 2023-03-31
Total revenue: 16243483.556638246
Gross profit: 7255188.7941534715
Operating income: 2328477.466504263
Net income: 1554031.6686967115
Capital expenditures: 10011595.615103533
Operating cash flow: 4061388.5505481125
Depreciation & amortization: 1825334.9573690624
Net tangible assets: 21114153.47137637
Owner earnings: -6632228.98903776
Return on net tangible assets (%): -31.411294788724597
Capex to operating income (%): 429.96317375292944
Buffett classification: The Gruesome
Stock price: 2.443361753958587
P/E ratio: 34.51124689229225
Shares outstanding: 21949910
Book value: 21114153.47137637
P/B ratio: 2.5400767627051373
Market cap (USD): 53631570.59683313
Debt to equity: 0.6875103837846819
Current ratio: 1.0261342553086066
Quick ratio: 0.7435682865463915
Effective tax rate (%): 24.39840958515297
Interest coverage ratio: 3.4836993166287016
COGS to revenue (%): 55.33477305618669
R&D to revenue (%): 0.558792432456752
SG&A to revenue (%): 0.9107746758748942
Free cash flow (dilution-adjusted): -5950207.064555421
Buyback yield (%): 0
Retained earnings: 8387904.993909867
Inventory turnover: 4.792589706121124
Receivables turnover: 6.040986242791847
Capitalized R&D asset: 100839.88754253979
ROCI (R&D-adjusted, %): 6.924034200847527
FCF margin (%): -36.63134846542041
Rule of 40 score: -36.63134846542041
Financial ratios for SAKAR.NS — annual report dated 2024-03-31
Total revenue: 18389699.00467682
Gross profit: 8355222.44873486
Operating income: 2536766.99844106
Net income: 1399556.3017148338
Capital expenditures: 7142367.190310589
Operating cash flow: 2934032.857656793
Depreciation & amortization: 2164588.0801055282
Net tangible assets: 31283607.147139944
Owner earnings: -3578222.808490227
Return on net tangible assets (%): -11.438012220458921
Capex to operating income (%): 281.55393044374375
Buffett classification: The Gruesome
Stock price: 4.418186180422265
P/E ratio: 69.29252428408012
Shares outstanding: 21949910
Book value: 31458340.328576565
P/B ratio: 3.0827687669020967
Market cap (USD): 96978789.02351248
Debt to equity: 0.30248643794045005
Current ratio: 1.2125387104366216
Quick ratio: 0.7429796326804977
Effective tax rate (%): 26.596728240155475
Interest coverage ratio: 3.136217402262383
COGS to revenue (%): 54.56574658122473
R&D to revenue (%): 0.4027343681224271
SG&A to revenue (%): 1.4105484321334552
Free cash flow (dilution-adjusted): -4208334.332653795
Buyback yield (%): 0
Retained earnings: 9657704.760762682
Inventory turnover: 3.017329972631192
Receivables turnover: 7.3329810736111245
Capitalized R&D asset: 139836.8643880272
ROCI (R&D-adjusted, %): 6.431075935721376
Rosenberg metric: 12.119265035041867
FCF margin (%): -22.884193654194902
Revenue growth (%): 13.21277816150142
Rule of 40 score: -9.671415492693482
Financial ratios for SAKAR.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 31796153.846153848
Buffett classification: The Gruesome
Stock price: 3.752986144290492
Shares outstanding: 21949910
Book value: 32192904.92116579
P/B ratio: 2.55887774962062
Market cap (USD): 82377708.09842332
Debt to equity: 0.2751460935963698
Current ratio: 1.1259919039662176
Quick ratio: 0.6525612970433396
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAKAR.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.4555309476628975
Shares outstanding: 21949910
Market cap (USD): 75848593.30341531
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAKAR.NS — annual report dated 2025-03-31
Total revenue: 20760427.870002337
Gross profit: 11143558.569090484
Operating income: 3366962.8244096325
Net income: 2046060.322656067
Capital expenditures: 3773977.0867430437
Operating cash flow: 3978501.285948094
Depreciation & amortization: 2441220.4816460134
Net tangible assets: 32834369.88543371
Owner earnings: 713303.7175590368
Return on net tangible assets (%): 2.1724300482936303
Capex to operating income (%): 112.08846915037674
Buffett classification: The Gruesome
Stock price: 2.4707667172365504
P/E ratio: 26.506113467825674
Shares outstanding: 21949910
Book value: 33373380.874444705
P/B ratio: 1.6250408455280636
Market cap (USD): 54233107.07433773
Debt to equity: 0.3025638941851133
Current ratio: 1.404220231981401
Quick ratio: 0.7143153320113126
Effective tax rate (%): 18.69858272983607
Interest coverage ratio: 3.3744581136496774
COGS to revenue (%): 46.32307850845259
R&D to revenue (%): 0.3603914075931091
SG&A to revenue (%): 1.1850119970920918
Free cash flow (dilution-adjusted): 204524.19920505024
Buyback yield (%): 0
Retained earnings: 11461012.391863454
Inventory turnover: 1.8870881162771493
Receivables turnover: 5.780168667875312
Capitalized R&D asset: 154393.32351175247
ROCI (R&D-adjusted, %): 8.137533644081278
Rosenberg metric: 37.64885833491831
FCF margin (%): 0.9851636993502255
Revenue growth (%): 12.89161320542876
Rule of 40 score: 13.876776904778986
Financial ratios for SAKAR.NS — quarterly report dated 2025-03-31
Total revenue: 5873486.088379705
Gross profit: 4158358.6626139814
Operating income: 1198000.9352349776
Net income: 673497.7788169277
Capital expenditures: 0
Depreciation & amortization: 640285.2466682254
Net tangible assets: 32834369.88543371
Owner earnings: 1313783.025485153
Return on net tangible assets (%): 4.001243301056878
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.4707667172365504
P/E ratio: 20.13113806017449
Shares outstanding: 21949910
Book value: 33373380.874444705
P/B ratio: 1.6250408455280636
Market cap (USD): 54233107.07433773
Debt to equity: 0.3025638941851133
Current ratio: 1.404220231981401
Quick ratio: 0.7143153320113126
Effective tax rate (%): 7.62286538924076
Interest coverage ratio: 2.4437687795106595
COGS to revenue (%): 29.201183078631733
Buyback yield (%): 0
Retained earnings: 11461012.391863454
Inventory turnover: 0.33655407823382055
Receivables turnover: 1.6353102388756342
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9106590671473596
Rule of 40 score: 0
Financial ratios for SAKAR.NS — quarterly report dated 2025-06-30
Total revenue: 6170863.561900305
Gross profit: 2783032.9978937516
Operating income: 834717.9967236135
Net income: 546606.5995787503
Capital expenditures: 0
Depreciation & amortization: 652036.0402527499
Owner earnings: 1198642.6398315001
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.126491926047273
P/E ratio: 74.23637517928044
Shares outstanding: 21949910
Market cap (USD): 90576126.39246431
Effective tax rate (%): 13.250259991086018
Interest coverage ratio: 3.32936619060954
COGS to revenue (%): 54.90042892737815
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.063048912449806
Rule of 40 score: 5.063048912449806
Financial ratios for SAKAR.NS — quarterly report dated 2025-09-30
Total revenue: 6489334.836527621
Gross profit: 3061330.3269447577
Operating income: 639244.6448703494
Net income: 511815.107102593
Capital expenditures: 0
Depreciation & amortization: 640789.1770011274
Net tangible assets: 33325422.77339346
Owner earnings: 1152604.2841037204
Return on net tangible assets (%): 3.45863364417373
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.040022547914318
P/E ratio: 51.20222508448618
Shares outstanding: 21949910
Book value: 34188602.02931228
P/B ratio: 2.593792260024554
Market cap (USD): 88678131.32468997
Debt to equity: 0.23696887976998737
Current ratio: 1.0829246912153292
Quick ratio: 0.5733684736945099
Effective tax rate (%): 15.26904197540081
Interest coverage ratio: 3.7137149593921928
COGS to revenue (%): 52.82520621816388
Buyback yield (%): 0
Inventory turnover: 0.6828832268424422
Receivables turnover: 1.799594812600828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5697303738024095
Revenue growth (%): 5.16088666412265
Rule of 40 score: 5.16088666412265
Financial ratios for SAKAR.NS — quarterly report dated 2025-12-31
Total revenue: 7835847.164977164
Gross profit: 3877163.863205971
Operating income: 1361267.6840815418
Net income: 1141706.583491144
Capital expenditures: 0
Depreciation & amortization: 709891.946084438
Owner earnings: 1851598.5295755821
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.558315695666704
P/E ratio: 34.81824596150687
Shares outstanding: 21949910
Market cap (USD): 100054619.27147155
Effective tax rate (%): 6.422278018717188
Interest coverage ratio: 6.88301227892306
COGS to revenue (%): 50.520169911745974
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 20.749620143966066
Rule of 40 score: 20.749620143966066
Financial ratios for SBH — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.85
Shares outstanding: 95408486
Market cap (USD): 1607632989.1000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBH — annual report dated 2022-09-30
Total revenue: 3815565000
Gross profit: 1919165000
Operating income: 365217000
Net income: 183553000
Capital expenditures: 99250000
Operating cash flow: 156500000
Depreciation & amortization: 99929000
Net tangible assets: -282745000
Owner earnings: 184232000
Return on net tangible assets (%): -65.1583582379883
Capex to operating income (%): 27.17562435483562
Buffett classification: The Good
Stock price: 12.6
P/E ratio: 6.549317764351441
Shares outstanding: 95408486
Book value: 293636000
P/B ratio: 4.094003880995518
Market cap (USD): 1202146923.6
Debt to equity: 5.905941369586835
Current ratio: 1.695429351683001
Quick ratio: 0.2934913776324497
Effective tax rate (%): 24.803254443930076
Interest coverage ratio: 3.904268625124274
COGS to revenue (%): 49.701682450698655
SG&A to revenue (%): 40.726550327408916
Free cash flow (dilution-adjusted): 47306000
Buyback yield (%): 10.841270517060783
Retained earnings: 440172000
Inventory turnover: 2.025259137908571
Receivables turnover: 52.790860162984075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.131796330239663
FCF margin (%): 1.2398163836810538
Rule of 40 score: 1.2398163836810538
Financial ratios for SBH — annual report dated 2023-09-30
Total revenue: 3728131000
Gross profit: 1898180000
Operating income: 342234000
Net income: 184600000
Capital expenditures: 90742000
Operating cash flow: 249311000
Depreciation & amortization: 102409000
Net tangible assets: -79504000
Owner earnings: 196267000
Return on net tangible assets (%): -246.86430871402698
Capex to operating income (%): 26.514606964825237
Buffett classification: The Good
Stock price: 8.38
P/E ratio: 4.331111119609968
Shares outstanding: 95408486
Book value: 508748000
P/B ratio: 1.5715503799130417
Market cap (USD): 799523112.6800001
Debt to equity: 3.293445871040279
Current ratio: 2.1199519384314733
Quick ratio: 0.4363848861558859
Effective tax rate (%): 26.76056338028169
Interest coverage ratio: 4.689486016525302
COGS to revenue (%): 49.08494363529608
SG&A to revenue (%): 41.735282370710685
Free cash flow (dilution-adjusted): 142707000
Buyback yield (%): 1.8948795550409077
Retained earnings: 624772000
Inventory turnover: 1.876453264808484
Receivables turnover: 49.13516968698517
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.947582308050398
FCF margin (%): 3.827842959380987
Revenue growth (%): -2.2915085970229834
Rule of 40 score: 1.5363343623580037
Financial ratios for SBH — annual report dated 2024-09-30
Total revenue: 3717031000
Gross profit: 1890332000
Operating income: 282658000
Net income: 153414000
Capital expenditures: 101165000
Operating cash flow: 246528000
Depreciation & amortization: 109738000
Net tangible assets: 30309000
Owner earnings: 161987000
Return on net tangible assets (%): 534.4518129928404
Capex to operating income (%): 35.790602070346495
Buffett classification: The Good
Stock price: 13.57
P/E ratio: 8.439211252036973
Shares outstanding: 95408486
Book value: 628535000
P/B ratio: 2.0598584884214883
Market cap (USD): 1294693155.02
Debt to equity: 2.5425250781579387
Current ratio: 2.2024333987436493
Quick ratio: 0.4533559204210107
Effective tax rate (%): 25.644492911668483
Interest coverage ratio: 3.6993246780441837
COGS to revenue (%): 49.14403458028733
SG&A to revenue (%): 43.251562873702156
Free cash flow (dilution-adjusted): 128191000
Buyback yield (%): 4.664580156760548
Retained earnings: 740685000
Inventory turnover: 1.7621615937890691
Receivables turnover: 40.320117585802926
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.846747839998546
FCF margin (%): 3.448747131783404
Revenue growth (%): -0.29773631881497725
Rule of 40 score: 3.151010812968427
Financial ratios for SBH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.57
Shares outstanding: 95408486
Market cap (USD): 1294693155.02
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.45
Shares outstanding: 95408486
Market cap (USD): 997018678.6999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBH — quarterly report dated 2025-03-31
Total revenue: 883146000
Gross profit: 458817000
Operating income: 69373000
Net income: 39210000
Capital expenditures: 18893000
Operating cash flow: 51064000
Depreciation & amortization: 25359000
Net tangible assets: 109822000
Owner earnings: 45676000
Return on net tangible assets (%): 41.590938063411706
Capex to operating income (%): 27.233938275698037
Buffett classification: The Good
Stock price: 9.03
P/E ratio: 5.493105257459831
Shares outstanding: 95408486
Book value: 699816000
P/B ratio: 1.231093071007236
Market cap (USD): 861538628.5799999
Debt to equity: 2.17503886735942
Current ratio: 2.323521304503545
Quick ratio: 0.4359889816254165
Effective tax rate (%): 26.135935498455275
Interest coverage ratio: 4.258886365031616
COGS to revenue (%): 48.04743496545305
SG&A to revenue (%): 44.097351966718975
Free cash flow (dilution-adjusted): 27933000
Buyback yield (%): 1.188455126716264
Retained earnings: 826154000
Inventory turnover: 0.42154511605358214
Receivables turnover: 9.295001736604465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.193113079276179
FCF margin (%): 3.1628971880074186
Rule of 40 score: 3.1628971880074186
Financial ratios for SBH — quarterly report dated 2025-06-30
Total revenue: 933307000
Gross profit: 480985000
Operating income: 78173000
Net income: 45724000
Capital expenditures: 20300000
Operating cash flow: 69431000
Depreciation & amortization: 24669000
Net tangible assets: 165744000
Owner earnings: 50093000
Return on net tangible assets (%): 30.223115165556518
Capex to operating income (%): 25.96804523300884
Buffett classification: The Good
Stock price: 9.26
P/E ratio: 10.401989549061623
Shares outstanding: 95408486
Book value: 762909000
P/B ratio: 1.158044511678326
Market cap (USD): 883482580.36
Debt to equity: 1.980540274134923
Current ratio: 2.4084437673955126
Quick ratio: 0.48922957685714397
Effective tax rate (%): 26.799436475409838
Interest coverage ratio: 4.976319307403399
COGS to revenue (%): 48.464438818095225
SG&A to revenue (%): 43.159646290020326
Free cash flow (dilution-adjusted): 44622000
Buyback yield (%): 1.4885409505913803
Retained earnings: 863251000
Inventory turnover: 0.4499082422801669
Receivables turnover: 9.72630449055306
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.520897120965221
FCF margin (%): 4.781063465719211
Revenue growth (%): 5.679808321613867
Rule of 40 score: 10.460871787333078
Financial ratios for SBH — quarterly report dated 2025-09-30
Total revenue: 947076000
Gross profit: 494106000
Operating income: 79944000
Net income: 49931000
Capital expenditures: 42874000
Operating cash flow: 120879000
Depreciation & amortization: 24328000
Net tangible assets: 200515000
Owner earnings: 31385000
Return on net tangible assets (%): 15.652195596339427
Capex to operating income (%): 53.6300410287201
Buffett classification: The Good
Stock price: 16.28
P/E ratio: 11.517073755829905
Shares outstanding: 95408486
Book value: 794207000
P/B ratio: 1.9557245807201398
Market cap (USD): 1553250152.0800002
Debt to equity: 1.9679579756914758
Current ratio: 2.259569008323292
Quick ratio: 0.54495168184675
Effective tax rate (%): 23.172439260820727
Interest coverage ratio: 5.346351902628236
COGS to revenue (%): 47.82826299050974
SG&A to revenue (%): 43.73059817797093
Free cash flow (dilution-adjusted): 73556000
Buyback yield (%): 1.3299853840243505
Retained earnings: 898076000
Inventory turnover: 0.45866896185099865
Receivables turnover: 8.125083646471406
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.48321352851831
FCF margin (%): 7.766641747863952
Revenue growth (%): 1.4752916242993999
Rule of 40 score: 9.241933372163352
Financial ratios for SBH — annual report dated 2025-09-30
Total revenue: 3701424000
Gross profit: 1910748000
Operating income: 327810000
Net income: 195878000
Capital expenditures: 58571000
Operating cash flow: 274831000
Depreciation & amortization: 99921000
Net tangible assets: 200515000
Owner earnings: 237228000
Return on net tangible assets (%): 118.30935341495649
Capex to operating income (%): 17.86736219151338
Buffett classification: The Great
Stock price: 16.28
P/E ratio: 7.929681496033245
Shares outstanding: 95408486
Book value: 794207000
P/B ratio: 1.9557245807201398
Market cap (USD): 1553250152.0800002
Debt to equity: 1.9679579756914758
Current ratio: 2.259569008323292
Quick ratio: 0.54495168184675
Effective tax rate (%): 25.639575274185038
Interest coverage ratio: 5.09077073594956
COGS to revenue (%): 48.37802964480697
SG&A to revenue (%): 42.76564911234163
Free cash flow (dilution-adjusted): 153437000
Buyback yield (%): 3.4763234967459984
Retained earnings: 898076000
Inventory turnover: 1.8132050730324278
Receivables turnover: 31.75498018222062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.282900865400618
FCF margin (%): 4.145350546168178
Revenue growth (%): -0.419878123157972
Rule of 40 score: 3.725472423010206
Financial ratios for SBH — quarterly report dated 2025-12-31
Total revenue: 943168000
Gross profit: 483259000
Operating income: 75935000
Net income: 45557000
Capital expenditures: 35784000
Operating cash flow: 93239000
Depreciation & amortization: 23632000
Net tangible assets: 229636000
Owner earnings: 33405000
Return on net tangible assets (%): 14.546935149541012
Capex to operating income (%): 47.124514387304934
Buffett classification: The Good
Stock price: 14.26
P/E ratio: 7.540793308798262
Shares outstanding: 95408486
Book value: 823565000
P/B ratio: 1.651994694237856
Market cap (USD): 1360525010.36
Debt to equity: 1.8714090569657527
Current ratio: 2.371368758876367
Quick ratio: 0.5660512385414169
Effective tax rate (%): 25.700073391502894
Interest coverage ratio: 5.19391244870041
COGS to revenue (%): 48.7621505394585
SG&A to revenue (%): 43.186791748659836
Free cash flow (dilution-adjusted): 49900000
Buyback yield (%): 1.525661038344868
Retained earnings: 923306000
Inventory turnover: 0.4698755298639441
Receivables turnover: 9.045699981777553
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2892115075404744
FCF margin (%): 5.290679921286558
Revenue growth (%): -0.41263847885491767
Rule of 40 score: 4.87804144243164
Financial ratios for SHV.AX — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.805755395683454
Shares outstanding: 141374561
Market cap (USD): 820786120.3381295
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHV.AX — annual report dated 2022-09-30
Total revenue: 129198701.2987013
Gross profit: 15374675.324675323
Operating income: -12540259.74025974
Net income: 3090259.74025974
Capital expenditures: 15713636.363636363
Depreciation & amortization: 13989610.38961039
Net tangible assets: 281333766.2337662
Owner earnings: 1366233.7662337646
Return on net tangible assets (%): 0.4856273687028851
Buffett classification: The Gruesome
Stock price: 3.3701298701298703
P/E ratio: 154.1781827253625
Shares outstanding: 141374561
Book value: 337846753.2467532
P/B ratio: 1.41025665134811
Market cap (USD): 476450630.9025974
Debt to equity: 0.7261092018974252
Current ratio: 2.550776974148602
Quick ratio: 0.6105410686335692
Effective tax rate (%): 21.85363383134971
Interest coverage ratio: -4.659107358262967
COGS to revenue (%): 88.09997688047203
SG&A to revenue (%): 9.904707336931937
Free cash flow (dilution-adjusted): -3514935.064935065
Buyback yield (%): 0
Retained earnings: 76033116.88311689
Inventory turnover: 0.9242275651165243
Receivables turnover: 5.0863029807249855
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1364273474205673
FCF margin (%): -2.7205653227184543
Rule of 40 score: -2.7205653227184543
Financial ratios for SHV.AX — annual report dated 2023-09-30
Total revenue: 131692307.69230768
Gross profit: -65063461.538461536
Operating income: -85831410.25641026
Net income: -73542948.71794872
Capital expenditures: 13825000
Depreciation & amortization: 8996153.846153846
Net tangible assets: 225000641.02564102
Owner earnings: -78371794.87179488
Return on net tangible assets (%): -34.83180959598406
Buffett classification: The Gruesome
Stock price: 2.5448717948717947
Shares outstanding: 141374561
Book value: 263798076.92307687
P/B ratio: 1.3638466853046596
Market cap (USD): 359780132.80128205
Debt to equity: 1.0229682279326895
Current ratio: 1.847047242316689
Quick ratio: 0.4393147109557741
Interest coverage ratio: -13.111731296513906
COGS to revenue (%): 149.40566588785046
SG&A to revenue (%): 8.938862928348911
Free cash flow (dilution-adjusted): -20020512.82051282
Buyback yield (%): 0
Retained earnings: 2454487.1794871795
Inventory turnover: 1.9691481581277184
Receivables turnover: 5.804701627486437
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.68450623845049
FCF margin (%): -15.202492211838006
Revenue growth (%): 1.9300553090245693
Rule of 40 score: -13.272436902813437
Financial ratios for SHV.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 289017241.37931037
Buffett classification: The Gruesome
Stock price: 2.5172413793103448
Shares outstanding: 141374561
Book value: 317649655.17241377
P/B ratio: 1.120334586032758
Market cap (USD): 355873894.93103445
Debt to equity: 0.912996752006114
Current ratio: 1.584762804914835
Quick ratio: 0.5852705773523438
Buyback yield (%): 0
Retained earnings: 3675172.413793104
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHV.AX — annual report dated 2024-09-30
Total revenue: 232302068.96551725
Gross profit: 22677241.379310347
Operating income: 297931.0344827586
Net income: 1034482.7586206897
Capital expenditures: 13346896.551724138
Depreciation & amortization: 9857241.379310345
Net tangible assets: 289017241.37931037
Owner earnings: -2455172.413793102
Return on net tangible assets (%): -0.8494899480999815
Capex to operating income (%): 4479.861111111111
Buffett classification: The Gruesome
Stock price: 2.5172413793103448
P/E ratio: 344.0114317666666
Shares outstanding: 141374561
Book value: 317649655.17241377
P/B ratio: 1.120334586032758
Market cap (USD): 355873894.93103445
Debt to equity: 0.912996752006114
Current ratio: 1.584762804914835
Quick ratio: 0.5852705773523438
Effective tax rate (%): -17.647058823529413
Interest coverage ratio: 0.028834601521826188
COGS to revenue (%): 90.23803727607931
SG&A to revenue (%): 5.39042507080555
Free cash flow (dilution-adjusted): -3116551.724137931
Buyback yield (%): 0
Retained earnings: 3675172.413793104
Inventory turnover: 1.5288998878309112
Receivables turnover: 3.6729802523253405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.05325706395778885
FCF margin (%): -1.3415944756826723
Revenue growth (%): 76.39759909764746
Rule of 40 score: 75.05600462196479
Financial ratios for SMHN.DE — annual report dated 2021-12-31
Total revenue: 299361363.6363636
Gross profit: 107034090.9090909
Operating income: 27102272.727272727
Net income: 18198863.636363637
Capital expenditures: 9611363.636363637
Operating cash flow: 27651136.363636363
Depreciation & amortization: 8012500
Net tangible assets: 150988636.36363637
Owner earnings: 16600000
Return on net tangible assets (%): 10.994204861895085
Capex to operating income (%): 35.46331236897275
Buffett classification: The Good
Stock price: 22.238636363636363
P/E ratio: 23.358793547299406
Shares outstanding: 19115538
Book value: 178268181.81818184
P/B ratio: 2.3846291252964122
Market cap (USD): 425103498.47727275
Debt to equity: 0.11676100869476527
Current ratio: 2.2593766565336395
Quick ratio: 1.1824377684260632
Effective tax rate (%): 27.520818247646634
Interest coverage ratio: 59.03465346534653
COGS to revenue (%): 64.24585671011775
R&D to revenue (%): 8.37160925910461
SG&A to revenue (%): 18.158352249865242
Free cash flow (dilution-adjusted): 16719318.181818182
Buyback yield (%): 0
Retained earnings: 89727272.72727273
Inventory turnover: 1.7001476659735406
Receivables turnover: 16.881640499839794
Capitalized R&D asset: 25061363.636363637
ROCI (R&D-adjusted, %): 18.465424228345537
FCF margin (%): 5.584995330969716
Rule of 40 score: 5.584995330969716
Financial ratios for SMHN.DE — annual report dated 2022-12-31
Total revenue: 276561702.1276596
Gross profit: 107044680.85106383
Operating income: 32778723.40425532
Net income: 26089361.70212766
Capital expenditures: 3018085.106382979
Operating cash flow: 25465957.446808513
Depreciation & amortization: 6290425.531914894
Net tangible assets: 163064893.6170213
Owner earnings: 29361702.127659574
Return on net tangible assets (%): 18.006145575772596
Capex to operating income (%): 9.20745164221732
Buffett classification: The Great
Stock price: 15.159574468085108
P/E ratio: 11.107340421627795
Shares outstanding: 19115538
Book value: 189074468.0851064
P/B ratio: 1.5326417402802002
Market cap (USD): 289783421.80851066
Debt to equity: 0.11255274855117312
Current ratio: 1.9493216476774757
Quick ratio: 0.8938475021910602
Effective tax rate (%): 25.444583293280786
Interest coverage ratio: 64.86736842105263
COGS to revenue (%): 61.29446701132446
R&D to revenue (%): 11.045590226489413
SG&A to revenue (%): 15.638078532742488
Free cash flow (dilution-adjusted): 21052127.659574468
Buyback yield (%): 0
Retained earnings: 106836170.21276596
Inventory turnover: 1.058517175179524
Receivables turnover: 13.613741097612067
Capitalized R&D asset: 47338985.97678917
ROCI (R&D-adjusted, %): 16.5085835068728
Rosenberg metric: 0.00042256048499932477
FCF margin (%): 7.612090718857704
Revenue growth (%): -7.616100231424292
Rule of 40 score: -0.0040095125665873255
Financial ratios for SMHN.DE — annual report dated 2023-12-31
Total revenue: 338068888.8888889
Gross profit: 115435555.55555555
Operating income: 29316666.666666664
Net income: 5218888.888888889
Capital expenditures: 3725555.5555555555
Operating cash flow: 4208888.888888889
Depreciation & amortization: 7627777.777777778
Net tangible assets: 169582222.2222222
Owner earnings: 9121111.111111112
Return on net tangible assets (%): 5.378577419016669
Capex to operating income (%): 12.70797801781315
Buffett classification: The Great
Stock price: 29.2
P/E ratio: 106.95259498403236
Shares outstanding: 19115538
Book value: 196241111.1111111
P/B ratio: 2.844326076425259
Market cap (USD): 558173709.6
Debt to equity: 0.08593736729759877
Current ratio: 1.8835602031311036
Quick ratio: 0.8816791369932991
Effective tax rate (%): 38.79532535395261
Interest coverage ratio: 83.49683544303797
COGS to revenue (%): 65.85442809157897
R&D to revenue (%): 10.290144677942035
SG&A to revenue (%): 14.977552241160577
Free cash flow (dilution-adjusted): -905555.5555555555
Buyback yield (%): 0
Retained earnings: 112555555.55555555
Inventory turnover: 1.2019219233630059
Receivables turnover: 17.204523607577045
Capitalized R&D asset: 63525102.24586289
ROCI (R&D-adjusted, %): 11.736572015026907
Rosenberg metric: 0.27467951322382783
FCF margin (%): -0.267861251158541
Revenue growth (%): 22.239950899939803
Rule of 40 score: 21.972089648781264
Financial ratios for SMHN.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.64444444444443
Shares outstanding: 19115538
Market cap (USD): 1388637638.2666664
Buyback yield (%): 0
Retained earnings: 211114444.44444445
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMHN.DE — annual report dated 2024-12-31
Total revenue: 465264583.3333334
Gross profit: 184196875
Operating income: 78769791.66666667
Net income: 114556250
Capital expenditures: 7131250
Operating cash flow: 34886458.333333336
Depreciation & amortization: 8146875
Net tangible assets: 270683333.3333334
Owner earnings: 115571875
Return on net tangible assets (%): 42.69633951111384
Capex to operating income (%): 9.053280260252054
Buffett classification: The Great
Stock price: 48.229166666666664
P/E ratio: 8.047805930492661
Shares outstanding: 19115538
Book value: 294898958.3333334
P/B ratio: 3.126245251374941
Market cap (USD): 921926468.125
Debt to equity: 0.04696170651670946
Current ratio: 2.4782508553034432
Quick ratio: 1.2947468357985923
Effective tax rate (%): 33.18727056512073
Interest coverage ratio: 191.9263959390863
COGS to revenue (%): 60.41029521732706
R&D to revenue (%): 8.94943289436566
SG&A to revenue (%): 13.407469764067937
Free cash flow (dilution-adjusted): 27007291.666666668
Buyback yield (%): 0
Inventory turnover: 1.2807824485456065
Receivables turnover: 16.548256826349526
Capitalized R&D asset: 75027150.6501182
ROCI (R&D-adjusted, %): 20.661922415491674
Rosenberg metric: 1.9765941901689612
FCF margin (%): 5.804716850179333
Revenue growth (%): 37.624193951265696
Rule of 40 score: 43.42891080144503
Financial ratios for SMHN.DE — quarterly report dated 2024-12-31
Total revenue: 157177083.33333334
Gross profit: 64063541.66666667
Operating income: 29922916.666666668
Net income: 17278125
Capital expenditures: 1840625
Operating cash flow: 4242708.333333334
Depreciation & amortization: 2219791.666666667
Net tangible assets: 267186458.33333334
Owner earnings: 17657291.666666668
Return on net tangible assets (%): 6.608602762583871
Capex to operating income (%): 6.151221889577386
Buffett classification: The Great
Stock price: 48.229166666666664
P/E ratio: 13.339503969976487
Shares outstanding: 19115538
Book value: 291402083.3333334
P/B ratio: 3.1637607308058016
Market cap (USD): 921926468.125
Debt to equity: 0.04752525505279789
Current ratio: 2.4232457221756496
Quick ratio: 1.2508725501476623
Effective tax rate (%): 41.39633286318759
Interest coverage ratio: 448.84375
COGS to revenue (%): 59.24116906355623
R&D to revenue (%): 8.031678706342369
SG&A to revenue (%): 13.550931141891445
Free cash flow (dilution-adjusted): 2116666.666666667
Buyback yield (%): 0
Inventory turnover: 0.41776222011394065
Receivables turnover: 10.153421707825853
Capitalized R&D asset: 12623958.333333334
ROCI (R&D-adjusted, %): 11.136898439950658
FCF margin (%): 1.3466763867718206
Rule of 40 score: 1.3466763867718206
Financial ratios for SMHN.DE — quarterly report dated 2025-03-31
Total revenue: 135780434.7826087
Gross profit: 53155434.782608695
Operating income: 24441304.347826086
Net income: 18047826.08695652
Capital expenditures: 1829347.8260869565
Operating cash flow: 11554347.826086955
Depreciation & amortization: 2069565.2173913042
Net tangible assets: 293609782.6086956
Owner earnings: 18288043.478260867
Return on net tangible assets (%): 6.228690105545293
Capex to operating income (%): 7.484657119985768
Buffett classification: The Great
Stock price: 35.326086956521735
P/E ratio: 9.353995799205011
Shares outstanding: 19115538
Book value: 318398913.04347825
P/B ratio: 2.1208525844322987
Market cap (USD): 675277157.6086956
Debt to equity: 0.0469127120408839
Current ratio: 2.5515811622006312
Quick ratio: 1.3299934176844876
Effective tax rate (%): 27.90273556231003
Interest coverage ratio: 247.0989010989011
COGS to revenue (%): 60.851918858771356
R&D to revenue (%): 8.700907795513857
SG&A to revenue (%): 12.809202837061113
Free cash flow (dilution-adjusted): 9673913.04347826
Buyback yield (%): 0
Inventory turnover: 0.35008013410949823
Receivables turnover: 8.05558779905849
Capitalized R&D asset: 20272182.51811594
ROCI (R&D-adjusted, %): 7.29965196269556
Rosenberg metric: -0.8640797597735503
FCF margin (%): 7.124673786003618
Revenue growth (%): -13.613084106763647
Rule of 40 score: -6.488410320760029
Financial ratios for SMHN.DE — quarterly report dated 2025-06-30
Total revenue: 168520000
Gross profit: 61471764.705882356
Operating income: 25317647.05882353
Net income: 14440000
Capital expenditures: 10850588.235294119
Operating cash flow: -31697647.05882353
Depreciation & amortization: 2482352.941176471
Net tangible assets: 323568235.2941176
Owner earnings: 6071764.705882352
Return on net tangible assets (%): 1.8765020924761753
Capex to operating income (%): 42.85780669144982
Buffett classification: The Good
Stock price: 52.54117647058823
P/E ratio: 20.181526394086593
Shares outstanding: 19115538
Book value: 350007058.82352936
P/B ratio: 2.8695217141166904
Market cap (USD): 1004352855.3882352
Debt to equity: 0.18763655186786152
Current ratio: 2.778061241263224
Quick ratio: 1.4169718647879173
Effective tax rate (%): 28.272802122404173
Interest coverage ratio: 215.2
COGS to revenue (%): 63.52257019589227
R&D to revenue (%): 8.70764161349325
SG&A to revenue (%): 13.965177810977227
Free cash flow (dilution-adjusted): -42875294.11764706
Buyback yield (%): 0
Inventory turnover: 0.43956155436609917
Receivables turnover: 8.246042254331932
Capitalized R&D asset: 26755491.288363174
ROCI (R&D-adjusted, %): 5.677694017007333
Rosenberg metric: 0.7039307691058762
FCF margin (%): -25.442258555451613
Revenue growth (%): 24.112137562240836
Rule of 40 score: -1.3301209932107767
Financial ratios for SMHN.DE — quarterly report dated 2025-09-30
Total revenue: 138778823.52941176
Gross profit: 45834117.64705882
Operating income: 14597647.05882353
Net income: 10803529.411764706
Capital expenditures: 7228235.294117647
Operating cash flow: 6968235.294117647
Depreciation & amortization: 3722352.941176471
Net tangible assets: 331598823.5294118
Owner earnings: 7297647.058823529
Return on net tangible assets (%): 2.200745762952398
Capex to operating income (%): 49.51644100580271
Buffett classification: The Good
Stock price: 34.305882352941175
P/E ratio: 10.826828830982322
Shares outstanding: 19115538
Book value: 357940000
P/B ratio: 1.8320819068591845
Market cap (USD): 655775397.7411765
Debt to equity: 0.16607121140907613
Current ratio: 2.92223997511453
Quick ratio: 1.494768395452746
Effective tax rate (%): 24.80759783854593
Interest coverage ratio: 24.37721021611002
COGS to revenue (%): 66.97326257608383
R&D to revenue (%): 9.21228870314169
SG&A to revenue (%): 13.929061901290247
Free cash flow (dilution-adjusted): -730588.2352941177
Buyback yield (%): 0
Inventory turnover: 0.39127247874084387
Receivables turnover: 4.721501761127121
Capitalized R&D asset: 26515027.749360617
ROCI (R&D-adjusted, %): 3.0066108255874133
Rosenberg metric: -1.065661829551832
FCF margin (%): -0.5264407181973857
Revenue growth (%): -17.648455062062805
Rule of 40 score: -18.17489578026019
Financial ratios for SMHN.DE — quarterly report dated 2025-12-31
Total revenue: 139745882.3529412
Gross profit: 48738823.52941176
Operating income: 7191764.705882353
Net income: 11398823.529411765
Capital expenditures: 4138823.529411765
Operating cash flow: 11045882.352941176
Depreciation & amortization: 5442352.94117647
Net tangible assets: 345460000
Owner earnings: 12702352.941176472
Return on net tangible assets (%): 3.6769388470956037
Capex to operating income (%): 57.549484704727625
Buffett classification: The Good
Stock price: 44.16470588235294
P/E ratio: 15.436631010453679
Shares outstanding: 19115538
Book value: 371155294.1176471
P/B ratio: 2.2746061471652896
Market cap (USD): 844232113.5529412
Debt to equity: 0.15730532962260918
Current ratio: 3.2823577346190413
Quick ratio: 1.8256060708950157
Effective tax rate (%): 10.00649772579597
Interest coverage ratio: 5.87223823246878
COGS to revenue (%): 65.1232489224138
R&D to revenue (%): 10.713564116379311
SG&A to revenue (%): 15.451575969827585
Free cash flow (dilution-adjusted): 6580000
Buyback yield (%): 0
Inventory turnover: 0.45074788628166207
Receivables turnover: 3.1433485935060466
Capitalized R&D asset: 28379976.470588233
ROCI (R&D-adjusted, %): 1.6475616064056773
Rosenberg metric: 0.22720161958222138
FCF margin (%): 4.708546605603448
Revenue growth (%): 0.6968345738458224
Rule of 40 score: 5.405381179449271
Financial ratios for SMHN.DE — annual report dated 2025-12-31
Total revenue: 591976470.5882353
Gross profit: 211023529.4117647
Operating income: 71077647.05882353
Net income: 54243529.4117647
Capital expenditures: 24197647.05882353
Operating cash flow: -1177647.0588235294
Depreciation & amortization: 13887058.823529413
Net tangible assets: 345460000
Owner earnings: 43932941.17647059
Return on net tangible assets (%): 12.717229542196085
Capex to operating income (%): 34.04396186440678
Buffett classification: The Good
Stock price: 44.16470588235294
P/E ratio: 15.563738619298588
Shares outstanding: 19115538
Book value: 371155294.1176471
P/B ratio: 2.2746061471652896
Market cap (USD): 844232113.5529412
Debt to equity: 0.15730532962260918
Current ratio: 3.2823577346190413
Quick ratio: 1.8256060708950157
Effective tax rate (%): 24.70464808648451
Interest coverage ratio: 34.70189546237794
COGS to revenue (%): 64.35271672165031
R&D to revenue (%): 9.331451965499424
SG&A to revenue (%): 14.094161135180256
Free cash flow (dilution-adjusted): -26555294.11764706
Buyback yield (%): 0
Inventory turnover: 1.8868177395013315
Receivables turnover: 13.315515096985893
Capitalized R&D asset: 94617789.58333334
ROCI (R&D-adjusted, %): 14.905284325985377
Rosenberg metric: 0.6442745912314342
FCF margin (%): -4.4858698676417985
Revenue growth (%): 27.234371966825734
Rule of 40 score: 22.748502099183934
Financial ratios for SMTI — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 220571
Buffett classification: The Gruesome
Stock price: 29.55
Shares outstanding: 9163969
Market cap (USD): 270795283.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMTI — annual report dated 2022-12-31
Total revenue: 45842845
Gross profit: 39481994
Operating income: -12232434
Net income: -7937497
Capital expenditures: 145466
Operating cash flow: -5554870
Depreciation & amortization: 2371068
Net tangible assets: 6715769
Owner earnings: -5711895
Return on net tangible assets (%): -85.05198734500844
Buffett classification: The Gruesome
Stock price: 45.5
Shares outstanding: 9163969
Book value: 41719975
P/B ratio: 9.994267482183295
Market cap (USD): 416960589.5
Debt to equity: 0.019636253377428917
Current ratio: 1.6098712751660138
Quick ratio: 1.3327422444671606
COGS to revenue (%): 13.875340851991188
R&D to revenue (%): 7.344727405116328
SG&A to revenue (%): 100.29117520956652
Free cash flow (dilution-adjusted): -9004518
Buyback yield (%): 0
Retained earnings: -23394757
Inventory turnover: 1.792293885601578
Receivables turnover: 6.545328369053655
Capitalized R&D asset: 3367032
ROCI (R&D-adjusted, %): -19.357556594044716
FCF margin (%): -19.642144810166123
Rule of 40 score: -19.642144810166123
Financial ratios for SMTI — annual report dated 2023-12-31
Total revenue: 64989842
Gross profit: 57137156
Operating income: -7665048
Net income: -4303197
Capital expenditures: 264596
Operating cash flow: -3245556
Depreciation & amortization: 3675026
Net tangible assets: -3695565
Owner earnings: -892767
Buffett classification: The Gruesome
Stock price: 41.1
Shares outstanding: 9163969
Book value: 44588017
P/B ratio: 8.44709299137479
Market cap (USD): 376639125.90000004
Debt to equity: 0.26446814174310557
Current ratio: 1.3804502320873435
Quick ratio: 1.0378024149983327
Interest coverage ratio: -16.110386457691845
COGS to revenue (%): 12.082943669873824
R&D to revenue (%): 6.358570620928729
SG&A to revenue (%): 87.69794054892456
Free cash flow (dilution-adjusted): -6953524
Buyback yield (%): 0
Retained earnings: -28036814
Inventory turnover: 1.6645746834203385
Receivables turnover: 7.616554367434774
Capitalized R&D asset: 6388336.4399999995
ROCI (R&D-adjusted, %): -9.072486200184933
Rosenberg metric: 5.243538522948401
FCF margin (%): -10.699401300283204
Revenue growth (%): 41.766598473545876
Rule of 40 score: 31.06719717326267
Financial ratios for SMTI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.24
Shares outstanding: 9163969
Market cap (USD): 277118422.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMTI — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 635625
Buffett classification: The Gruesome
Stock price: 33.2
Shares outstanding: 9163969
Market cap (USD): 304243770.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SMTI — annual report dated 2024-12-31
Total revenue: 86672425
Gross profit: 78532524
Operating income: 1244390
Net income: -9664547
Capital expenditures: 205848
Operating cash flow: -23784
Depreciation & amortization: 4923224
Net tangible assets: 12320697
Owner earnings: -4947171
Return on net tangible assets (%): -40.153337104223894
Capex to operating income (%): 16.54208085889472
Buffett classification: The Great
Stock price: 33.2
Shares outstanding: 9163969
Book value: 38911962
P/B ratio: 7.81877230451654
Market cap (USD): 304243770.8
Debt to equity: 0.8296941696232125
Current ratio: 2.1782755619643623
Quick ratio: 1.998221983403478
Interest coverage ratio: 0.3977726597824124
COGS to revenue (%): 9.391569463990422
R&D to revenue (%): 3.263625080295146
SG&A to revenue (%): 82.69486171639942
Free cash flow (dilution-adjusted): -4689132
Buyback yield (%): 0
Retained earnings: -37784392
Inventory turnover: 2.9567040993348424
Receivables turnover: 6.3960815632185195
Capitalized R&D asset: 6708508.3100000005
ROCI (R&D-adjusted, %): 0.7927844671492108
Rosenberg metric: 5.1774364931002985
FCF margin (%): -5.410177458401562
Revenue growth (%): 33.363033872278066
Rule of 40 score: 27.952856413876503
Financial ratios for SMTI — quarterly report dated 2025-03-31
Total revenue: 23434096
Gross profit: 21599129
Operating income: 825530
Net income: -3527177
Capital expenditures: 1662649
Operating cash flow: -1998884
Depreciation & amortization: 1124410
Net tangible assets: -8944770
Owner earnings: -4065416
Capex to operating income (%): 201.40382542124456
Buffett classification: The Gruesome
Stock price: 30.87
Shares outstanding: 9163969
Book value: 36667577
P/B ratio: 7.7150372665747735
Market cap (USD): 282891723.03000003
Debt to equity: 1.2196028114974709
Current ratio: 2.7740678733730113
Quick ratio: 2.536181500641327
Interest coverage ratio: 0.6267823356303128
COGS to revenue (%): 7.830329789551088
R&D to revenue (%): 4.055454070001249
SG&A to revenue (%): 81.62980982923344
Free cash flow (dilution-adjusted): -5026437
Buyback yield (%): 0
Retained earnings: -41311569
Inventory turnover: 0.5807993462012507
Receivables turnover: 1.9685369707352482
Capitalized R&D asset: 950359
ROCI (R&D-adjusted, %): 1.736037339507909
FCF margin (%): -21.4492464313537
Rule of 40 score: -21.4492464313537